Cargando…

Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma

The development of hepatocellular carcinoma (HCC) is an important complication of viral infection induced by hepatitis virus C, and our major research theme is to identify a new growth factor related to the progression of HCC. HDGF (hepatoma-derived growth factor) is a novel growth factor that belon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enomoto, Hirayuki, Nakamura, Hideji, Liu, Weidong, Nishiguchi, Shuhei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490540/ https://www.ncbi.nlm.nih.gov/pubmed/26101867 http://dx.doi.org/10.3390/ijms160614086

Ejemplares similares

Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
por: Enomoto, Hirayuki, et al.
Publicado: (2017)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Diagnosis of Spontaneous Bacterial Peritonitis and an In Situ Hybridization Approach to Detect an “Unidentified” Pathogen
por: Enomoto, Hirayuki, et al.
Publicado: (2014)

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Hepatoma-derived growth factor and its role in keloid pathogenesis
por: Ooi, BNS, et al.
Publicado: (2010)

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Role of hepatoma‐derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma
por: Min, Xuejie, et al.
Publicado: (2018)

Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Frailty and Sleep Disorder in Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy
por: Yuri, Yukihisa, et al.
Publicado: (2017)

Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013)

An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients
por: Enomoto, Hirayuki, et al.
Publicado: (2014)

A New Metabolism-Related Index Correlates with the Degree of Liver Fibrosis in Hepatitis C Virus-Positive Patients
por: Enomoto, Hirayuki, et al.
Publicado: (2015)

Corrigendum to “An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients”
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Anthropometric Measurements and Frailty in Patients with Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
por: Ishii, Noriko, et al.
Publicado: (2020)

Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases
por: Yoh, Kazunori, et al.
Publicado: (2020)

Correction: Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013)

Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

MiRNA-610 acts as a tumour suppressor to depress the cisplatin resistance in hepatocellular carcinoma through targeted silencing of hepatoma-derived growth factor
por: Xu, Yongqing, et al.
Publicado: (2019)

NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma
por: Zhang, Ye-wei, et al.
Publicado: (2021)

Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin
por: Liu, Chunhua, et al.
Publicado: (2019)

Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen
por: Everett, Allen D, et al.
Publicado: (2011)

Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex
por: Bremer, Stephanie, et al.
Publicado: (2013)

The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye
por: LeBlanc, Michelle E., et al.
Publicado: (2016)

Impact of Hepatoma-Derived Growth Factor Blockade on Resiniferatoxin-Induced Neuropathy
por: Wu, Chieh-Hsin, et al.
Publicado: (2021)

Neuroprotective effects of hepatoma-derived growth factor in models of Huntington’s disease
por: Voelkl, Kerstin, et al.
Publicado: (2023)

Long non-coding RNA MKLN1-AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR-654-3p, thereby promoting hepatoma-derived growth factor expression
por: Gao, Wanjun, et al.
Publicado: (2020)

MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF
por: Huge, Nicole, et al.
Publicado: (2022)

Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation
por: Sedlmaier, Angela, et al.
Publicado: (2011)

Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer
por: Liu, Xue-jun, et al.
Publicado: (2015)

Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas
por: Yang, Yang, et al.
Publicado: (2017)

Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin
por: Wistner, Sarah C., et al.
Publicado: (2023)

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
por: Aizawa, Nobuhiro, et al.
Publicado: (2013)

Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
por: Sakai, Yoshiyuki, et al.
Publicado: (2014)

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j0nqd627b21epd4gm8qvk291fu